Mk801-induced caspase-3 in the postnatal brain: Inverse relationship with calcium binding proteins

Neuroscience

Volumn 141, Issue 3, 2006, Pages 1351-1363

  Tomé, C M Lema ^a   Bauer, C ^a   Nottingham, C ^a   Smith, C ^a   Blackstone, K ^a   Brown, L ^a   Hlavaty, C ^a   Nelson, C ^a   Daker, R ^a   Sola, R ^a   Miller, R ^a   Bryan, R ^a   Turner, C P ^a  

^a WAKE FOREST SCHOOL OF MEDICINE   (United States)

Author keywords

calcium buffering; development; glutamate; NMDA; rat

Indexed keywords

CALBINDIN; CALCIUM BINDING PROTEIN; CALRETININ; CASPASE 3; DIZOCILPINE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT; PARVALBUMIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; APOPTOSIS; ARTICLE; BRAIN CORTEX; BRAIN REGION; CELL POPULATION; CONTROLLED STUDY; ENZYME ACTIVATION; IMMUNOREACTIVITY; NONHUMAN; PERINATAL PERIOD; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BINDING; PROTEIN EXPRESSION; RAT; SOMATOSENSORY CORTEX;

AGE FACTORS; ANALYSIS OF VARIANCE; ANIMALS; ANIMALS, NEWBORN; BRAIN; CALCIUM-BINDING PROTEINS; CASPASE 3; CASPASES; CELL COUNT; DIZOCILPINE MALEATE; DOSE-RESPONSE RELATIONSHIP, DRUG; EXCITATORY AMINO ACID ANTAGONISTS; GENE EXPRESSION REGULATION, DEVELOPMENTAL; IMMUNOHISTOCHEMISTRY; RATS; RATS, SPRAGUE-DAWLEY;

EID: 33746396573     PISSN: 03064522     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuroscience.2006.05.019     Document Type: Article

References (69)

1. Airaksinen M.S., Thoenen H., and Meyer M. Vulnerability of midbrain dopaminergic neurons in calbindin-D28k-deficient mice. lack of evidence for a neuroprotective role of endogenous calbindin in MPTP-treated and weaver mice. Eur J Neurosci 9 (1997) 120-127
2. Alcantara S., Soriano E., and Ferrer I. Thalamic and basal forebrain afferents modulate the development of parvalbumin and calbindin D28k immunoreactivity in the barrel cortex of the rat. Eur J Neurosci 8 (1996) 1522-1534
3. Baimbridge K.G., Celio M.R., and Rogers J.H. Calcium-binding proteins in the nervous system. Trends Neurosci 15 (1992) 303-308
4. Berridge M.J., Lipp P., and Bootman M.D. The versatility and universality of calcium signalling. Nat Rev Mol Cell Biol 1 (2000) 11-21
5. Bonfoco E., Krainc D., Ankarcrona M., Nicotera P., and Lipton S.A. Apoptosis and necrosis. two distinct events induced, respectively, by mild and intense insults with N-methyl-D-aspartate or nitric oxide/superoxide in cortical cell cultures. Proc Natl Acad Sci U S A 92 (1995) 7162-7166
6. Bouilleret V., Schwaller B., Schurmans S., Celio M.R., and Fritschy J.M. Neurodegenerative and morphogenic changes in a mouse model of temporal lobe epilepsy do not depend on the expression of the calcium-binding proteins parvalbumin, calbindin, or calretinin. Neuroscience 97 (2000) 47-58
7. Boukhaddaoui H., Sieso V., Scamps F., Vigues S., Roig A., and Valmier J. Q- and L-type calcium channels control the development of calbindin phenotype in hippocampal pyramidal neurons in vitro. Eur J Neurosci 12 (2000) 2068-2078
8. Burke R.E., and Baimbridge K.G. Relative loss of the striatal striosome compartment, defined by calbindin-D28k immunostaining, following developmental hypoxic-ischemic injury. Neuroscience 56 (1993) 305-315
9. Celio M.R. Calbindin D-28k and parvalbumin in the rat nervous system. Neuroscience 35 (1990) 375-475
10. Choi D.W. Glutamate neurotoxicity in cortical cell culture is calcium dependent. Neurosci Lett 58 (1985) 293-297
11. Defelipe J., Huntley G.W., Delrio M.R., Sola R.G., and Morrison J.H. Microzonal decreases in the immunostaining for non-NMDA ionotropic excitatory amino-acid receptor subunits Glur-2/3 and Glur-5/6/7 in the human epileptogenic neocortex. Brain Res 657 (1994) 150-158
12. D'Orlando C., Celio M.R., and Schwaller B. Calretinin and calbindin D-28k, but not parvalbumin protect against glutamate-induced delayed excitotoxicity in transfected N18-RE 105 neuroblastoma-retina hybrid cells. Brain Res 945 (2002) 181-190
13. Dowd D.R., MacDonald P.N., Komm B.S., Haussler M.R., and Miesfeld R.L. Stable expression of the calbindin-D28K complementary DNA interferes with the apoptotic pathway in lymphocytes. Mol Endocrinol 6 (1992) 1843-1848
14. Enderlin S., Norman A.W., and Celio M.R. Ontogeny of the calcium binding protein calbindin D-28k in the rat nervous system. Anat Embryol (Berl) 177 (1987) 15-28
15. Fierro L., and Llano I. High endogenous calcium buffering in Purkinje cells from rat cerebellar slices. J Physiol 496 Pt 3 (1996) 617-625
16. Freund T.F., and Magloczky Z. Early degeneration of calretinin-containing neurons in the rat hippocampus after ischemia. Neuroscience 56 (1993) 581-596
17. Freund T.F., Ylinen A., Miettinen R., Pitkanen A., Lahtinen H., Baimbridge K.G., and Riekkinen P.J. Pattern of neuronal death in the rat hippocampus after status epilepticus. Relationship to calcium binding protein content and ischemic vulnerability. Brain Res Bull 28 (1992) 27-38
18. Friauf E. Distribution of calcium-binding protein calbindin-D-28k in the auditory-system of adult and developing rats. J Comp Neurol 349 (1994) 193-211
19. Haberny K.A., Paule M.G., Scallet A.C., Sistare F.D., Lester D.S., Hanig J.P., and Slikker Jr. W. Ontogeny of the N-methyl-D-aspartate (NMDA) receptor system and susceptibility to neurotoxicity. Toxicol Sci 68 (2002) 9-17
20. Hack N.J., Wride M.C., Charters K.M., Kater S.B., and Parks T.N. Developmental changes in the subcellular localization of calretinin. J Neurosci 20 (2000) RC67
21. Hagberg H., Gilland E., Diemer N.H., and Andine P. Hypoxia-ischemia in the neonatal rat brain. histopathology after post-treatment with NMDA and non-NMDA receptor antagonists. Biol Neonate 66 (1994) 205-213
22. Heizmann C.W. Calcium-binding proteins. basic concepts and clinical implications. Gen Physiol Biophys 11 (1992) 411-425
23. Hof P.R., Cox K., Young W.G., Celio M.R., Rogers J., and Morrison J.H. Parvalbumin-immunoreactive neurons in the neocortex are resistant to degeneration in Alzheimer's disease. J Neuropathol Exp Neurol 50 (1991) 451-462
24. Hof P.R., Glezer I.I., Conde F., Flagg R.A., Rubin M.B., Nimchinsky E.A., and Vogt Weisenhorn D.M. Cellular distribution of the calcium-binding proteins parvalbumin, calbindin, and calretinin in the neocortex of mammals. phylogenetic and developmental patterns. J Chem Neuroanat 16 (1999) 77-116
25. Iacopino A., Christakos S., German D., Sonsalla P.K., and Altar C.A. Calbindin-D28K-containing neurons in animal models of neurodegeneration. possible protection from excitotoxicity. Brain Res Mol Brain Res 13 (1992) 251-261
26. Iacopino A.M., Christakos S., Modi P., and Altar C.A. Nerve growth factor increases calcium binding protein (calbindin-D28K) in rat olfactory bulb. Brain Res 578 (1992) 305-310
27. Ikenaga T, Heusa G, Finger TE (2005) Co-occurrence of calcium binding proteins and calcium fluxing ionotrpic glutamate receptors in the primary gustatory nucleus of goldfish. Proceedings of the 35th Annual Society for Neuroscience Meeting, Washington, DC, 280.16.
28. Ikonomidou C., Bosch F., Miksa M., Bittigau P., Vockler J., Dikranian K., Tenkova T.I., Stefovska V., Turski L., and Olney J.W. Blockade of NMDA receptors and apoptotic neurodegeneration in the developing brain. Science 283 (1999) 70-74
29. Isaacs K.R., Wolpoe M.E., and Jacobowitz D.M. Vulnerability to calcium-induced neurotoxicity in cultured neurons expressing calretinin. Exp Neurol 163 (2000) 311-323
30. Johnson Jr. E.M., Koike T., and Franklin J. A "calcium set-point hypothesis" of neuronal dependence on neurotrophic factor. Exp Neurol 115 (1992) 163-166
31. Klapstein G.J., Vietla S., Lieberman D.N., Gray P.A., Airaksinen M.S., Thoenen H., Meyer M., and Mody I. Calbindin-D28k fails to protect hippocampal neurons against ischemia in spite of its cytoplasmic calcium buffering properties. evidence from calbindin-D28k knockout mice. Neuroscience 85 (1998) 361-373
32. Koh J.Y., and Cotman C.W. Programmed cell death. its possible contribution to neurotoxicity mediated by calcium channel antagonists. Brain Res 587 (1992) 233-240
33. Kortekaas P., and Wadman W.J. Development of HVA and LVA calcium currents in pyramidal CA1 neurons in the hippocampus of the rat. Dev Brain Res 101 (1997) 139-147
34. Lee S.H., Schwaller B., and Neher E. Kinetics of Ca2+ binding to parvalbumin in bovine chromaffin cells. implications for [Ca2+] transients of neuronal dendrites. J Physiol Lond 525 (2000) 419-432
35. Lledo P.M., Somasundaram B., Morton A.J., Emson P.C., and Mason W.T. Stable transfection of calbindin-D28k into the GH3 cell line alters calcium currents and intracellular calcium homeostasis. Neuron 9 (1992) 943-954
36. Lowenstein D.H., Miles M.F., Hatam F., and McCabe T. Up regulation of calbindin-D28K mRNA in the rat hippocampus following focal stimulation of the perforant path. Neuron 6 (1991) 627-633
37. Lukas W., and Jones K.A. Cortical neurons containing calretinin are selectively resistant to calcium overload and excitotoxicity in vitro. Neuroscience 61 (1994) 307-316
38. Mattson M.P., Rychlik B., Chu C., and Christakos S. Evidence for calcium-reducing and excito-protective roles for the calcium-binding protein calbindin-D28k in cultured hippocampal neurons. Neuron 6 (1991) 41-51
39. Mockel V., and Fischer G. Vulnerability to excitotoxic stimuli of cultured rat hippocampal neurons containing the calcium-binding proteins calretinin and calbindin D28K. Brain Res 648 (1994) 109-120
40. Monyer H., Burnashev N., Laurie D.J., Sakmann B., and Seeburg P.H. Developmental and regional expression in the rat brain and functional properties of four NMDA receptors. Neuron 12 (1994) 529-540
41. Moran J., Itoh T., Reddy U.R., Chen M., Alnemri E.S., and Pleasure D. Caspase-3 expression by cerebellar granule neurons is regulated by calcium and cyclic AMP. J Neurochem 73 (1999) 568-577
42. Moulder K.L., Fu T., Melbostad H., Cormier R.J., Isenberg K.E., Zorumski C.F., and Mennerick S. Ethanol-induced death of postnatal hippocampal neurons. Neurobiol Dis 10 (2002) 396-409
43. Mulholland P.J., Harris B.R., Wilkins L.H., Self R.L., Blanchard J.A., Holley R.C., Littleton J.M., and Prendergast M.A. Opposing effects of ethanol and nicotine on hippocampal calbindin-D28k expression. Alcohol 31 (2003) 1-10
44. Nagerl U.V., Novo D., Mody I., and Vergara J.L. Binding kinetics of calbindin-D(28k) determined by flash photolysis of caged Ca(2+). Biophys J 79 (2000) 3009-3018
45. Olney J.W., Ikonomidou C., Mosinger J.L., and Frierdich G. MK-801 prevents hypobaric-ischemic neuronal degeneration in infant rat brain. J Neurosci 9 (1989) 1701-1704
46. Olney J.W., Wozniak D.F., Jevtovic-Todorovic V., Farber N.B., Bittigau P., and Ikonomidou C. Drug-induced apoptotic neurodegeneration in the developing brain. Brain Pathol 12 (2002) 488-498
47. Paxinos G. The rat nervous system (2004), Elsevier, San Diego
48. Paxinos G., and Watson A. The rat brain in stereotaxic coordinates (1998), Academic Press, San Diego
49. Prendergast M.A., Harris B.R., Mayer S., Holley R.C., Hauser K.F., and Littleton J.M. Chronic nicotine exposure reduces N-methyl-D-aspartate receptor-mediated damage in the hippocampus without altering calcium accumulation or extrusion. evidence of calbindin-D28K overexpression. Neuroscience 102 (2001) 75-85
50. Resibois A., and Rogers J.H. Calretinin in rat-brain. an immunohistochemical study. Neuroscience 46 (1992) 101-134
51. Rintoul G.L., Raymond L.A., and Baimbridge K.G. Calcium buffering and protection from excitotoxic cell death by exogenous calbindin-D28k in HEK 293 cells. Cell Calcium 29 (2001) 277-287
52. Schierle G.S., Gander J.C., D'Orlando C., Ceilo M.R., and Vogt Weisenhorn D.M. Calretinin-immunoreactivity during postnatal development of the rat isocortex. a qualitative and quantitative study. Cereb Cortex 7 (1997) 130-142
53. Schlosser B., Klausa G., Prime G., and Ten Bruggencate G. Postnatal development of calretinin- and parvalbumin-positive interneurons in the rat neostriatum. an immunohistochemical study. J Comp Neurol 405 (1999) 185-198
54. Schwaller B., Meyer M., and Schiffmann S. "New" functions for "old" proteins: the role of the calcium-binding proteins calbindin D-28k, calretinin and parvalbumin, in cerebellar physiology. Studies with knockout mice. Cerebellum 1 (2002) 241-258
55. Setzer M., and Ulfig N. Differential expression of calbindin and calretinin in the human fetal amygdala. Microsc Res Tech 46 (1999) 1-17
56. Silverstein F.S., Buchanan K., Hudson C., and Johnston M.V. Flunarizine limits hypoxia-ischemia induced morphologic injury in immature rat brain. Stroke 17 (1986) 477-482
57. Silverstein F.S., McDonald III J.W., Bommarito M., and Johnston M.V. Effects of hypoxia-ischemia and MK-801 treatment on the binding of a phencyclidine analogue in the developing rat brain. Stroke 21 (1990) 310-315
58. Sleeper AA, Hertle DN, Fitzpatrick JS, Falco JJ, Yeckel M (2005) Upregulation of calcium binding protein calbindin during development regulates internal calcium release and calcium waves in CA1 pyramidal cells. Proceedings of the 35th Annual Society for Neuroscience Meeting, Washington, DC, 968.15.
59. Takadera T., Matsuda I., and Ohyashiki T. Apoptotic cell death and caspase-3 activation induced by N-methyl-D-aspartate receptor antagonists and their prevention by insulin-like growth factor I. J Neurochem 73 (1999) 548-556
60. Takadera T., and Ohyashiki T. Apoptotic cell death and CPP32-like activation induced by thapsigargin and their prevention by nerve growth factor in PC12 cells. Biochim Biophys Acta 1401 (1998) 63-71
61. Turner CP, Connell J, Blackstone K, Ringler SL (2006a) Loss of calcium and increased apoptosis within the same neuron. Brain Res, in press.
62. Turner CP, Miller R, Smith C, Brown L, Blackstone K, Dunham SR, Srehlow R, Manfredi M, Slocum P, Iverson K, West M, Ringler SL, Berry ZC (2006b) Widespread neonatal brain damage following calcium channel blockade. Dev Neurosci, in press.
63. Turner C.P., Pulciani D., and Rivkees S.A. Reduction in intracellular calcium levels induces injury in developing neurons. Exp Neurol 178 (2002) 21-32
64. Uematsu D., Greenberg J.H., Araki N., and Reivich M. Mechanism underlying protective effect of MK-801 against NMDA-induced neuronal injury in vivo. J Cereb Blood Flow Metab 11 (1991) 779-785
65. Wang C., Fridley J., and Johnson K.M. The role of NMDA receptor upregulation in phencyclidine-induced cortical apoptosis in organotypic culture. Biochem Pharmacol 69 (2005) 1373-1383
66. Watanabe M., Inoue Y., Sakimura K., and Mishina M. Developmental changes in distribution of NMDA receptor channel subunit mRNAs. Neuroreport 3 (1992) 1138-1140
67. Yoon W.J., Won S.J., Ryu B.R., and Gwag B.J. Blockade of ionotropic glutamate receptors produces neuronal apoptosis through the Bax-cytochrome C-caspase pathway. the causative role of Ca2+ deficiency. J Neurochem 85 (2003) 525-533
68. Yu B., Wang C., Liu J., Johnson K.M., and Gallagher J.P. Adaptation to chronic PCP results in hyperfunctional NMDA and hypofunctional GABA(A) synaptic receptors. Neuroscience 113 (2002) 1-10
69. Zipfel G.J., Babcock D.J., Lee J.M., and Choi D.W. Neuronal apoptosis after CNS injury. the roles of glutamate and calcium. J Neurotrauma 17 (2000) 857-869